REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/14/2025
Back to search
Official data from USPTO
RENEO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
04/15/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/09/2018
Registration date
04/14/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2020
Last transaction
04/15/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/25/2020
First use in commerce
01/25/2020
Drawing code
4
Owner type
03
Owner location
Irvine, CA
Examiner
ALI, STEPHANIE
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.
Representatives
Brandon P. Leahy WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis
Publications
History of USPTO decisions and trademark events.
40 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/30/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/10/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/08/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/10/2020
EX3G
SOU EXTENSION 3 GRANTED
02/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/10/2020
IUAF
USE AMENDMENT FILED
02/05/2020
EXT3
SOU EXTENSION 3 FILED
02/05/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/05/2020
EISU
TEAS STATEMENT OF USE RECEIVED
02/05/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/04/2019
EX2G
SOU EXTENSION 2 GRANTED
12/02/2019
EXT2
SOU EXTENSION 2 FILED
12/02/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/08/2019
EX1G
SOU EXTENSION 1 GRANTED
05/06/2019
EXT1
SOU EXTENSION 1 FILED
05/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/06/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/18/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/23/2018
PUBO
PUBLISHED FOR OPPOSITION
10/23/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/03/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/14/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2018
ALIE
ASSIGNED TO LIE
08/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/10/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/30/2018
GNRT
NON-FINAL ACTION E-MAILED
06/30/2018
CNRT
NON-FINAL ACTION WRITTEN
06/30/2018
DOCK
ASSIGNED TO EXAMINER
06/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2018
NWAP
NEW APPLICATION ENTERED
03/13/2018
Continuous trademark protection
Get notified about every new filing that threatens RENEO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.